Cover Image

Ivermectin and doxycycline treatments against Onchocerciasis: Adaptations and impact among semi-nomadic population in Massangam Health District, Cameroon.

We trialed strategies to reach semi-nomadic population with interventions targeting onchocerciasis including a combination of community knowledge and Geographical Information System (GIS) technology; nomad-specific sensitization; and mobile outreach. The interventions included ivermectin (ivm) mass...

Full description

Saved in:

Bibliographic Details
Main Authors:	Rogers Nditanchou (Author), Ruth Dixon (Author), Kareen Atekem (Author), Benjamin Biholong (Author), Aude Wilhelm (Author), Richard Selby (Author), Joseph Oye (Author), Joseph Kamgno (Author), Daniel Boakye (Author), Elena Schmidt (Author), Laura Senyonjo (Author)
Format:	Book
Published:	Public Library of Science (PLoS), 2023-07-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Correction: Ivermectin and doxycycline treatments against Onchocerciasis: Adaptations and impact among semi-nomadic population in Massangam Health District, Cameroon.
by: Rogers Nditanchou, et al.
Published: (2024)

Acceptability of test and treat with doxycycline against Onchocerciasis in an area of persistent transmission in Massangam Health District, Cameroon.
by: Rogers Nditanchou, et al.
Published: (2023)

Cost of implementing a doxycycline test-and-treat strategy for onchocerciasis elimination among settled and semi-nomadic groups in Cameroon.
by: Guillaume Trotignon, et al.
Published: (2023)

Correction: Ivermectin and doxycycline treatments against Onchocerciasis: Adaptations and impact among semi-nomadic population in Massangam Health District, Cameroon
Published: (2024)

Evaluating the impact of alternative intervention strategies in accelerating onchocerciasis elimination in an area of persistent transmission in the West Region of Cameroon.
by: Kareen Atekem, et al.
Published: (2022)

On-going transmission of human onchocerciasis in the Massangam health district in the West Region of Cameroon: Better understanding transmission dynamics to inform changes in programmatic interventions.
by: Didier Bakajika, et al.
Published: (2018)

Factors Associated with Ivermectin Non-Compliance and Its Potential Role in Sustaining Onchocerca volvulus Transmission in the West Region of Cameroon.
by: Laura Senyonjo, et al.
Published: (2016)

Adherence to ivermectin is more associated with perceptions of community directed treatment with ivermectin organization than with onchocerciasis beliefs.
by: Fanny Nadia Dissak-Delon, et al.
Published: (2017)

Relationship between skin snip and Ov16 ELISA: Two diagnostic tools for onchocerciasis in a focus in Cameroon after two decades of ivermectin-based preventive chemotherapy.
by: Linda Djune-Yemeli, et al.
Published: (2022)

The Mbam drainage system and onchocerciasis transmission post ivermectin mass drug administration (MDA) campaign, Cameroon.
by: Raphael Awah Abong, et al.
Published: (2021)

Epidemiology of onchocerciasis-associated epilepsy in the Mbam and Sanaga river valleys of Cameroon: impact of more than 13 years of ivermectin
by: Joseph Nelson Siewe Fodjo, et al.
Published: (2018)

Would ivermectin for malaria control be beneficial in onchocerciasis-endemic regions?
by: Joseph Nelson Siewe Fodjo, et al.
Published: (2019)

Dynamics of Onchocerca volvulus microfilarial densities after ivermectin treatment in an ivermectin-naïve and a multiply treated population from Cameroon.
by: Sébastien D S Pion, et al.
Published: (2013)

Reproductive status of Onchocerca volvulus after ivermectin treatment in an ivermectin-naïve and a frequently treated population from Cameroon.
by: Hugues C Nana-Djeunga, et al.
Published: (2014)

Evaluation of Lymphatic Filariasis and Onchocerciasis in Three Senegalese Districts Treated for Onchocerciasis with Ivermectin.
by: Nana O Wilson, et al.
Published: (2016)

Can ivermectin mass treatments eliminate onchocerciasis in Africa?
by: Winnen M., et al.
Published: (2002)

Can ivermectin mass treatments eliminate onchocerciasis in Africa?
by: M. Winnen, et al.

Programmatic factors associated with the limited impact of Community-Directed Treatment with Ivermectin to control Onchocerciasis in three drainage basins of South West Cameroon.
by: Christian Tetteh Duamor, et al.
Published: (2017)

Impact of short-term discontinuation of ivermectin-based chemoprevention on onchocerciasis transmission in endemic settings with long history of mass drug administration.
by: Arnauld Efon-Ekangouo, et al.
Published: (2023)

The impact of ivermectin on onchocerciasis in villages co-endemic for lymphatic filariasis in an area of onchocerciasis recrudescence in Burkina Faso.
by: Achille S Nikièma, et al.
Published: (2021)

Impact of five annual rounds of mass drug administration with ivermectin on onchocerciasis in Sierra Leone
by: Joseph B. Koroma, et al.
Published: (2018)

Prevalence of epilepsy in the onchocerciasis endemic middle belt of Ghana after 27 years of mass drug administration with ivermectin
by: Kenneth Bentum Otabil, et al.
Published: (2023)

Uncertainty surrounding projections of the long-term impact of ivermectin treatment on human onchocerciasis.
by: Hugo C Turner, et al.
Published: (2013)

Interruption of infection transmission in the onchocerciasis focus of Ecuador leading to the cessation of ivermectin distribution.
by: Raquel Lovato, et al.
Published: (2014)

Comparison of Doxycycline, Minocycline, Doxycycline plus Albendazole and Albendazole Alone in Their Efficacy against Onchocerciasis in a Randomized, Open-Label, Pilot Trial.
by: Ute Klarmann-Schulz, et al.
Published: (2017)

Impact of repeated annual community directed treatment with ivermectin on loiasis parasitological indicators in Cameroon: Implications for onchocerciasis and lymphatic filariasis elimination in areas co-endemic with Loa loa in Africa.
by: Samuel Wanji, et al.
Published: (2018)

Low prevalence of epilepsy and onchocerciasis after more than 20 years of ivermectin treatment in the Imo River Basin in Nigeria
by: Joseph N. F. Siewe, et al.
Published: (2019)

Ivermectin as an adjuvant to anti-epileptic treatment in persons with onchocerciasis-associated epilepsy: A randomized proof-of-concept clinical trial.
by: Michel Mandro, et al.
Published: (2020)

Serious limitations of the current strategy to control Soil-Transmitted Helminths and added value of Ivermectin/Albendazole mass administration: A population-based observational study in Cameroon.
by: Linda Djune-Yemeli, et al.
Published: (2020)

Assessment of the performance of community-directed treatment with ivermectin strategy for the control and elimination of onchocerciasis in Edo State, Nigeria
by: Amenze Oritsemofe Onowhakpor, et al.
Published: (2017)

The cost of annual versus biannual community-directed treatment of onchocerciasis with ivermectin: Ghana as a case study.
by: Hugo C Turner, et al.
Published: (2013)

Nomad
by: Smith, George O. (George Oliver), 1911-1981; Orban, Paul, 1896-1974 [Illustrator]

Impact of ivermectin and vector control on onchocerciasis transmission in Togo: Assessing the empirical evidence on trends in infection and entomological indicators.
by: Natalie V S Vinkeles Melchers, et al.
Published: (2024)

Feasibility of onchocerciasis elimination with ivermectin treatment in endemic foci in Africa: first evidence from studies in Mali and Senegal.
by: Lamine Diawara, et al.
Published: (2009)

Immunoepidemiological profiling of onchocerciasis patients reveals associations with microfilaria loads and ivermectin intake on both individual and community levels.
by: Kathrin Arndts, et al.
Published: (2014)

Mass Administration of Ivermectin for the Elimination of Onchocerciasis Significantly Reduced and Maintained Low the Prevalence of Strongyloides stercoralis in Esmeraldas, Ecuador.
by: Mariella Anselmi, et al.
Published: (2015)

Genetic selection of low fertile Onchocerca volvulus by ivermectin treatment.
by: Catherine Bourguinat, et al.
Published: (2007)

Proof-of-principle of onchocerciasis elimination with ivermectin treatment in endemic foci in Africa: final results of a study in Mali and Senegal.
by: Mamadou O Traore, et al.
Published: (2012)

African Program for Onchocerciasis Control 1995-2010: Impact of Annual Ivermectin Mass Treatment on Off-Target Infectious Diseases.
by: Stanimira P Krotneva, et al.
Published: (2015)

Potential Value of Triple Drug Therapy with Ivermectin, Diethylcarbamazine, and Albendazole (IDA) to Accelerate Elimination of Lymphatic Filariasis and Onchocerciasis in Africa.
by: Peter U Fischer, et al.
Published: (2017)